December 10, 2019
Sanofi announced a major strategy shift today that will end the pharma’s diabetes and cardiovascular R&D efforts in favor of a reinvigorated focus on growing its immunology and vaccine businesses.
Among the fallout of this new game plan is Onduo, the pharma’s diabetes management joint venture with Verily that the two companies invested $500 million into back in 2016, according to the company’...
November 7, 2019
Fitbit’s year-over-year device sales flatlined in Q3 2019, which combined with lower sales tag prices drove a decline in revenue, according to the wearables maker’s latest quarterly earnings.
The reporting — which was bereft of an investor’s call, Q&A and any forward-looking statements due to the company’s pending acquisition — is the latest look at a wearables business Google apparently...
November 5, 2019
Friday marked the end of Dr. Ned Sharpless’ time as acting commissioner of the FDA, with President Donald Trump pointing to Dr. Stephen Hahn, currently the chief medical officer of MD Anderson Cancer Center, as his official appointment for the role on Friday. Assistant Secretary for health at HHS Dr. Brett Giroir will act as the agency’s new acting head.
“With Dr. Sharpless at the helm, the FDA...
November 1, 2019
After a month of rumors, this morning Google and Fitbit announced that the former has officially purchased the wearable giant for roughly $2.1 billion, or $7.35 per share, in cash.
Fitbit stressed that its devices will remain platform-agnostic across the Android and iOS ecosystems. Still, a blog post from Google discussing the acquisition made it clear that we can also expect to see some Google...
October 30, 2019
Articles referenced in today's episode:
Alphabet makes offer to acquire Fitbit
Facebook's new tool tells users what checkups they need, where to get them
Amazon makes its second digital health acquisition with Health Navigator
October 29, 2019
Alphabet serious about health wearables? Alphabet has reportedly put in an unspecified offer to buy out Fitbit, according to anonymous sources talking to Reuters. The news comes roughly a month after another report from the outlet suggesting that the wearables maker had brought on investment firm Qatalyst Partners to explore a potential sale, in which Alphabet was name dropped as a potential...
October 1, 2019
Sixth time's the charm? Roche’s Accu-Chek Connect Diabetes Management App has notched its sixth device recall from the FDA, this time due to meter-to-app data transfer issues for users with Android OS 8.0 and above. According to the agency’s posting, Roche notified partners, users and call centers of the issue and released and update addressing the problem before the end of that month.
September 18, 2019
This morning Google announced that the health team at DeepMind, an artificial intelligence Alphabet subsidiary primarily focused on research, is joining Google Health.
“Under the leadership of Dr. David Feinberg, and alongside other teams at Google, we’ll now be able to tap into global expertise in areas like app development, data security, cloud storage and user-centered design to build...
September 5, 2019
Alphabet’s life science branch Verily is teaming up with digital health startup iRhythm on a new initiative focused on creating screening, diagnosis and management tools for patients with atrial fibrillation.
The collaboration is specifically targeted at alerting patients with asymptomatic or silent atrial fibrillation about their condition. The goal is to develop products that not only identify...
August 7, 2019
Nearly five years after Alphabet purchased DeepMind, an AI-focused technology entity, it is still continuing to report massive losses on the subsidiary. Yesterday DeepMind released its latest strategic report, revealing that its losses for the financial year were £470 million, or roughly $571 million.
Deep Mind has been heavily involved in the healthcare space, using its AI platform for diagnosis...